LowrieE.G., LairdN.M., ParkerT.F., SargentJ.A.. Effects of hemodialysis prescription on patient morbidity: Report from the National Cooperative Dialysis Study.N Engl J Med1981; 305: 1176–81.
2.
GotchF.D., SargentJ.A.. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS).Kidney Int1985; 28: 526–34.
3.
HeldP.J., PortF.K., WolfR.A., StannardD.C., CarrollC.E., DaugirdasJ.T.The dose of hemodialysis and patient mortality.Kidney Int1996; 50: 550–6.
4.
FleischmannE., TealN., DudleyJ., MayW., BowerJ.D., SalahudeenA.K.. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients.Kidney Int1999; 55: 1560–7.
5.
KoppleJ.D., ZhuX., LewD.L., LowrieE.G.. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients.Kidney Int1999; 56: 1136–48.
6.
LowrieE.G., ChertowG.M., LewN.L., LazarusJ.M., OwenW.F.. The urea product (Kt) as an outcome-based measure of hemodialysis dose.Kidney Int1999; 56: 729–37.
7.
PortF.K., AshbyV.B., DhingraR.K., RoysE.L., WolfeR.A.. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients.J Am Soc Nephrol2002; 13: 1061–6.
8.
TeehanB.P., SchleiferC.R., SiglerM.H., GilgoreG.S.. A quantitative approach to the CAPD prescription.Perit Dial Bull1985; 5: 152–6.
9.
KeshaviahP.R., NolphK.D., Van StoneJ.C.. The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis.Perit Dial Int1989; 9: 267–60.
10.
ChurchillD.N., TaylorD.W., KeshaviahP.R., ThorpeK.E., BeecroftM.L.. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
11.
BargmanJ.M., ThorpeK.F., ChurchillD.N.. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study.J Am Soc Nephrol2001; 12: 2158–62.
12.
Diaz-BuxoJ.A., LowrieE.G., LewN.L., ZhangH., ZhuX., LazarusJ.M.. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance.Am J Kidney Dis1999; 3: 523–34.
13.
BhaskaranS., SchaubelD.E., JassalS.V.The effect of small solute clearances on survival of anuric peritoneal dialysis patients.Perit Dial Int2000; 20: 181–7.
SzetoC.C., WongT.Y.H., ChowK.M., LeungC.B., LawM.C., WangA.Y.M.Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis.J Am Soc Nephrol2001; 12: 355–60.
16.
PaniaguaR., AmatoD., VoneshE., Correa-RotterR., RamosA., MoranJ.Effects of increased peritoneal clearance on mortality rates in peritoneal dialysis: ADEMEX, a prospective randomized controlled trial.J Am Soc Nephrol2002; 13: 1307–20.
17.
ChatothD.K., GolperT.A., GokalR.. Morbidity and mortality in redefining adequacy of peritoneal dialysis: A step beyond the National Kidney Foundation Dialysis Outcomes Quality Initiative.Am J Kidney Dis1999; 33: 617–32.
18.
MerkusM.P., JagerK.J., DekkerF.W., de HaanR.J., BoeschotenE.W., KredietR.T.. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group.Am J Kidney Dis2000; 35: 69–79.
19.
JagerK.J., MerkusM.P., DekkerF.W., BoeschotenE.W., TijssenJ.G.P., StevensP.Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis.Kidney Int1999; 55: 1476–85.
20.
ScribnerB.H., BuriR., CanerJ.E.J., HegstromR., BurnellJ.M.. The treatment of chronic uremia by means of intermittent hemodialysis: A preliminary report.ASAIO Trans1960; 6: 114–22.
21.
TzamaloukasA.H., SaddlerM.C., MurataG.H., MalhotraD., SenaP., SimonD.Symptomatic fluid retention in patients on continuous peritoneal dialysis.J Am Soc Nephrol1995; 6: 198–206.
22.
CocchiR., EspostiE.D., FabbriA., LucatelloA., SturaniA., QuarelloF.Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study.Nephrol Dial Transplant1999; 14: 1536–40.
23.
LangS.M., WolframG., GergerR., SchifflH.. Characterization of subtypes of hypertension in CAPD patients by cyclic guanosine monophosphate.Perit Dial Int1999; 19: 143–7.
24.
TakedaK., NakamotoM., BabaM., TanakaT., YasunagaC., MishikavaG.Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients.Clin Nephrol1998; 49: 308–12.
25.
BuoncristianiU., CeravoloG., BovaC.. Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD).Contrib Nephrol1996; 119: 152–6.
GoodmanW.G., GoldinJ., KuisonB.D., YoonC., CalesB., SiderD.Coronary artery calcification in young adults with end-stage renal disease who are undergoing hemodialysis.N Engl J Med2000; 342: 1478–83.
28.
ChertowG.M., BurkeS.K., RaggiP., for the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.Kidney Int2002; 62: 245–52.
